B-cell receptor specific for H5N1 hemagglutinin (BCR-H5N1-HA)

B-cell receptors (BCRs) specific for the H5N1 hemagglutinin (HA) protein are membrane-bound immunoglobulins on the surface of B lymphocytes that recognize and bind to the HA surface glycoprotein of the H5N1 avian influenza virus (Source: CDC, 2023). Upon binding to the HA antigen, these receptors initiate intracellular signaling pathways that lead to B-cell activation, proliferation, and differentiation into antibody-secreting plasma cells and memory B cells (Source: Janeway's Immunobiology, 2017). This process is the fundamental basis for the efficacy of H5N1 vaccines, which aim to elicit a robust and specific BCR response to provide protective immunity against highly pathogenic avian influenza (Source: WHO, 2024). Therapeutic strategies often focus on identifying and stimulating BCRs that recognize conserved epitopes on the HA stalk or head to generate broadly neutralizing antibodies against diverse H5N1 strains (Source: Nature Communications, 2021). Understanding the repertoire and affinity of these receptors is crucial for pandemic preparedness and the development of next-generation influenza vaccines (Source: NIH, 2022).

Other names

H5N1 HA-specific B-cell receptorAnti-H5N1 hemagglutinin BCRH5N1-specific BCRHemagglutinin-specific B-cell receptor

Antigen-mediated activation of B-cell receptors leads to clonal expansion and differentiation into plasma cells that secrete neutralizing antibodies against the H5N1 hemagglutinin protein.